Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX Inhibitors
Open Access
- 14 September 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 13 (10) , 2849-2854
Abstract
Targeting the protein–protein interaction between p53 and MDM2/MDMX (MDM4) represents an attractive anticancer strategy for the treatment of p53-competent tumors. Several selective and potent MDM2 inhibitors have been developed and entered the clinic; however, the repertoire of MDMX antagonists is still limited. The arylmethylidenepyrazolinone SJ-172550 has been reported as a selective MDMX antagonist; yet, uncertainties about its mechanism of action have raised doubts about its use as a chemical probe. Here, we show that, in addition to its unclear mode of action, SJ-172550 is unstable in aqueous buffers, giving rise to side products of unknown biological activity. Using an SJ-172550-derived affinity probe, we observed promiscuous binding to cellular proteins whereas cellular thermal shift assays did not reveal a stabilizing effect on MDMX. Overall, our results raise further questions about the interpretation of data using SJ-172550 and related compounds to investigate cellular phenotypes.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (EP/L016044/1)
- FP7 Joint Technology Initiatives (115766)
- Medical Research Council (EP/L016044/1)
- Wellcome (106169/ZZ14/Z)
- Structural Genomics Consortium (1097737)
This publication has 41 references indexed in Scilit:
- On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53PLOS ONE, 2012
- Identification and Characterization of the First Small Molecule Inhibitor of MDMXJournal of Biological Chemistry, 2010
- Coping with stress: multiple ways to activate p53Oncogene, 2007
- The Phospha‐Michael Addition in Organic SynthesisEuropean Journal of Organic Chemistry, 2005
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Control of apoptosis by p53Oncogene, 2003
- p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53Oncogene, 1999
- p53, guardian of the genomeNature, 1992
- Untersuchungen zur Hydrolysestabilität von 4-Arylmethyliden-2-pyrazolin-5-onenJournal für Praktische Chemie, 1985
- Syntheses of 1,3-disubstituted 4-arylidenepyrazolin-5-ones and the keto and enol forms of 4,4'-arylidenebis(1,3-disubstituted pyrazolin-5-ones)Journal of Chemical & Engineering Data, 1984